Comments on Proposed Rule: Amendments to the Accelerated Filer and Large Accelerated Filer Definitions

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment Council of State Bioscience Associations
Public Comment Jeffrey P. Mahoney, General Counsel, Council of Institutional Investors
Public Comment PricewaterhouseCoopers LLP
Public Comment Advanced Medical Technology Association, et al.
Public Comment Andrew Allen, CEO, Gritstone Oncology Inc.
Public Comment Christpher Cole, Executive Vice President and Senior Regulatory Counsel, Independent Community Bankers of America
Public Comment Daniel Menold, Vice President of Finance, CymaBay Therapeutics, Inc.
Public Comment Damian Finio, Chief Financial Officer, Teligent Inc.
Public Comment Janice L. Gray, Chair, and Ken L. Bishop, President and CEO, National Association of State Boards of Accountancy
Public Comment Shaun A. Burke, President and Chief Executive Officer, Guaranty Federal Bancshares, Inc.
Public Comment Colleen Honigsberg, Associate Professor of Law, Stanford Law School, et al.
Public Comment Jason Keyes, Chief Financial Officer, Equillium, Inc.
Public Comment Joseph Ferra, Chief Financial Officer, Syros Pharmaceuticals, Inc.
Public Comment Tobin C. Schilke, CFO, Revance Therapeutics Inc
Public Comment Alfred G. Merriweather, Chief Executive Officer, Adamas Pharmaceuticals, Inc.
Public Comment Leiv Lea, Chief Financial Officer, Corvus Pharmaceuticals
Public Comment Michael A. Pisetsky, General Counsel, SI-BONE, Inc.
Public Comment Michael A. Shriner, President/CEO, MSB Financial Corp
Public Comment Marilyn J. Bruno, CEO, Aequor, inc.
Public Comment Mark Kaufmann, Chief Financial Officer, Ardelyx, Inc.
Public Comment Taylor Crouch, Chief Executive Officer, Organovo, Inc.
Public Comment David Vandertie, Vice President, Finance, Evoke Pharma, Inc.
Public Comment Grant Thornton LLP
Public Comment Marc Belsky, Chief Financial Officer, Kezar Life Sciences
Public Comment Michael McNamara, Director of Finance and Controller, Marinus Pharmaceuticals Inc
Public Comment Nancy J. Schroeder, CPA, Chair, Financial Reporting Committee, and Heather Bain, CPA, MBA, CMA, Chair, Small Business Committee; Institute of Management Accountants
Public Comment Ahmed S. Mousa, General Counsel, Pieris Pharmaceuticals
Public Comment Mark J. Fitzpatrick, President, Chiasma, Inc.
Public Comment Mary Barth, Professor, Stanford Graduate School of Business; Wayne Landsman, Professor, Kenan-Flagler Business School; Joseph Schroeder, Professor, Kelley School of Business; and Daniel Taylor, Professor, The Wharton School
Public Comment Lisa Walters-Hoffert, Chief Financial Officer, Dare Bioscience, Inc.

Last Reviewed or Updated: Dec. 18, 2025

File Number
S7-06-19
Release Number
34-85814
Related Materials
How to submit comments